Fresh Equities
ASX:ATX

ASX:ATX

AMPLIA THERAPEUTICS LIMITED

AMPLIA THERAPEUTICS LIMITED has not announced any current capital raises, but we are collecting interest for future raises.

Demand Registered for Next Raise
< $50k
Investors Interested in Next Raise
< 10
How Fresh Equities Works
Authentication

1. Create Account

Complete your onboarding digitally in less than 3 minutes.

Authentication

2. View Terms

View the full term sheet for the capital raise.

Authentication

3. Bid for Allocation

Submit and track your bid online.

Capital Raise History

Loading...


Company Overview

Amplia Therapeutics Limited (ASX:ATX) is an Australian pharmaceutical company that is advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Amplia has two core patent families over its FAK assets. Their ideology is that FAK is an increasingly important target in the field of cancer immunology and that FAK inhibition has the potential to sensitize treatment-resistant cancers to the existing chemotherapeutics. With FAK in mind, Amplia has a particular development focus in pancreatic and ovarian cancer.

Type

Listed Company

GICS Sub-industry

Biotechnology

Head Office

226/55 Flemington Rd, Parkville VIC 3052, Australia

Biotechnology
Health Care
Biotech & Health
Pharmaceuticals

Price Chart


Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.

Loading...


Directors


Announcements

All
All Time

Loading...


News

Loading...